Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the Light Study, a long-term research study of Contrave® (naltrexone SR/bupropion SR), a new, investigational drug being evaluated for weight loss, has begun enrolling patients at clinical sites throughout the United States. The Light Study is designed to assess the cardiovascular health outcomes of Contrave.
Nearly 93 million Americans are affected by obesity, and that number is predicted to increase to 120 million Americans within the next five years. More than one-third of adults in the United States are affected by obesity. Obesity increases the risk of heart disease, type 2 diabetes, some types of cancer, sleep apnea, and a variety of other conditions. Medical research suggests that losing just five percent of your body weight can significantly improve your health and reduce the risk of complications from type 2 diabetes and heart disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56480-lightstudy
- MegaForexInvest is formed by a group of professional traders from USA
and Germany with years of research in the investment field.
MegaForexInvest has worked offline since 2005. Today, we offer our
website to all the people who want invest on forex but doesn't have the
necesary knowledge to do itself. Our expert group, has constantly
analyze market variation and trends to generate possitive balances. For
these reason we guarantee that your invest will be in the correct way.
Official video source http://www.youtube.com/watch?v=YoRMYXF1YQE
Furniture, today news videos & online blog articles. Search High
Point furniture market today & design show video ideas. USA
business online industry surveys, home accents ideas videos, research
analysis & the list reports the best investment in the home
furnishings industry is to put future investments in the next
generation for a better tomorrow.